CGB MEDIA Company newsCann Global and their JV partners visited the two BioHealth sites recently. Dr. Benjamin Rosenstein from Pharmocann, the VP of R & D, met up with the team from Medcan, BioHealth T12, and HHC, and the Senior Management team from Cann Global to inspect and assess the capabilities of the two Biohealth facilities. Dr. Rosenstein was very impressed with the manufacturing infrastructure already in place and expressed confidence in the whole team from Cann Global. We are looking forward to commencing manufacturing operations.
CGB Price at posting:
2.6¢ Sentiment: Buy Disclosure: Held